CXCR3 gene as a therapeutic target in colorectal cancer

Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, Mehrdad Behmanesh · 2025

Read CXCR3 gene as a therapeutic target in colorectal cancer by Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, Mehrdad Behmanesh (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12817714.txt.

Description

Seyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, and Mehrdad Behmanesh study the CXCR3 gene as a therapeutic target in colorectal cancer. Their 2025 paper notes that current treatments often fail or bring side effects, so new targets are needed.

CXCR3, a member of the GPCR family, is raised in colorectal cancer. The team designed specific DNAzymes to target the gene in the HCT-116 cancer cell line. They then assessed cell cycle, cell death by staining, and wound healing to see how lowering CXCR3 affects cancer cell growth. Downregulation held back a key AKT and MTOR related path, the opening results show.

Catalog record

CREATORSeyedeh Zohreh Azarshin, Melina Malmir, Seyedeh Fatemeh Sajjadi, Mehrdad Behmanesh
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12817714

Browse the full library · About the Tower of Babel